In-person exams required before abortions

Summary#

HF 2788 amends several parts of the Iowa Code and repeals Chapter 146C. It sets rules for abortion definitions, medical examinations and consent, dispensing abortion-inducing drugs, and reporting. Its stated aim is to address abortion-related provisions; it does not promise a particular outcome. The enrolled bill is signed into law and took effect July 1, 2026.

  • Before performing an abortion, a physician must examine the patient in person and screen for signs of coercion or abuse. If needed, the physician must refer the patient to a health care provider for treatment.
  • Before prescribing or dispensing abortion-inducing drugs for a chemical abortion, a physician must collect a signed FDA patient agreement form and written confirmation that the patient received specified risk information. The physician must also explain how to access emergency surgical care.
  • Abortion-inducing drugs generally must be dispensed directly to the patient in a health care setting, by someone authorized under Iowa law. A medical emergency is an exception.
  • The bill creates civil liability for some unlawful dispensing and allows a successful plaintiff to seek damages, court costs, and attorney fees. It does not impose civil or criminal liability on the woman who had the abortion.
  • Abortion reporting must include whether mifepristone or misoprostol was used. Reports of a spontaneous pregnancy termination must include whether the patient took either drug in the prior 14 days.

What it means for you#

  • Patients seeking an abortion: A physician must conduct an in-person examination before performing an abortion. For a chemical abortion, the physician must provide the specified information and get written confirmation that you received it. The bill does not require you to have the recommended follow-up visit; it requires the physician to tell you that the FDA recommends one about 7 to 14 days later.
  • Patients seeking abortion-inducing drugs: The drugs generally must be given directly to you in a health care setting. The bill exempts dispensing in response to a medical emergency. It does not make you civilly or criminally liable for an abortion.
  • Physicians and other dispensers: Physicians who fail to follow the examination or drug-consent rules may face professional discipline. People who dispense drugs outside the bill’s rules may face a civil lawsuit, subject to the bill’s exemption for people subject to discipline under Chapters 148 or 155A.
  • Health care providers and state reporting: The bill changes what abortion-related reports must include. It defines abortion to exclude miscarriage treatment, removal of pregnancy tissue after an incomplete or inevitable loss, and ectopic-pregnancy treatment.
  • Iowa Board of Medicine: The board must adopt rules to administer the chemical-abortion requirements. The bill also repeals Chapter 146C; the supplied material does not show what provisions that chapter contained.

Money#

No cost estimate is included in the available material.

  • The bill requires the Board of Medicine to adopt rules, but gives no staffing or cost estimate and appropriates no money.
  • Physicians, dispensers, and health care settings may face compliance costs; the amount is not stated.
  • The bill allows damages, court costs, and attorney fees in some lawsuits. It does not estimate how many cases may be brought or their cost.

What is unclear#

  • The current versions of the amended Code sections and the repealed Chapter 146C were not supplied. I could not verify which amended wording is new and what legal rules Chapter 146C contained.
  • The bill does not set out how the in-person examination or coercion screening must be conducted, or how referrals should work.
  • It does not explain how to determine whether a drug was dispensed “in response to a medical emergency.”
  • It does not explain how the new reporting information will be used or who may access it.
  • The bill refers to who is authorized to dispense drugs under another Code section, but that section was not supplied, so the full set of authorized dispensers cannot be confirmed.

Case for#

  • A possible argument for the bill is that an in-person examination and screening may help identify coercion, abuse, or a need for treatment before an abortion.
  • Requiring patients to receive written information about specified risks and how to get emergency surgical care may help them make an informed decision and respond to complications.
  • Requiring dispensing directly to the patient in a health care setting may make it clearer who is responsible for dispensing the drugs.
  • Reporting whether certain drugs were used may give the state more information about abortion and pregnancy-loss cases.

Case against#

  • The mandatory in-person examination and direct-dispensing rule may make access to abortion-inducing drugs harder for some patients. The bill does not explain how patients will be accommodated if they cannot attend in person or reach a health care setting.
  • The bill requires detailed disclosures, including that some women have experienced trauma from seeing pregnancy remains. It does not explain how the required information was selected or how physicians should present it.
  • The bill creates civil lawsuits for some unlawful dispensing but does not explain how disputed claims about damages caused by the drug would be resolved.
  • The bill adds reporting about drug use around pregnancy loss, but the available text does not explain safeguards for that information or how the state will use it.

Votes

The recorded vote on this bill, member by member.

  1. Division No. 1693359

    Passed87 members voted

    Shall the bill pass?

    FOR · 58AGAINST · 29

    58For

    • Republican58

    29Against

    • Democratic27
    • Republican2

    13 members were paired and sat out the vote.